• Bausch Health makes $200m bid for bankrupt Synergy Pharmaceuticals pharmaceutical-technology
    December 17, 2018
    Canada-based Bausch Health Companies (previously Valeant Pharmaceuticals) has entered a definitive agreement to acquire select assets of Synergy Pharmaceuticals for around $200m and certain assumed liabilities.....
  • Bausch Health buy bankrupt Synergy Pharmaceuticals for $200m pharmafile
    December 14, 2018
  • Synergy Pharmaceuticals inks deal with Luxion Pharma biospectrumasia
    August 13, 2018
PharmaSources Customer Service